Navigation Links
Treating osteoporosis calls for physician, dentist collaboration: ADA Journal
Date:5/15/2008

CHICAGO, May 15, 2008 Physicians and dentists should collaborate to improve early detection and treatment of patients who have or may develop osteoporosis, say researchers in the cover story of the May issue of The Journal of the American Dental Association.

The authors of the article, Osteoporosis and Its Implications for Dental Patients, reviewed the medical and dental literature to examine osteoporosis effect on public health in the United States. They also assessed the implications of providing dental care to people who have or are at risk of developing osteoporosis.

According to the authors, the literature indicated that osteoporosis and related fractures are more common than coronary disease, stroke and breast cancer. Fractures resulting from osteoporosis can affect a patients quality of life, as well as result in functional impairment and increased health care cost and mortality.

Their literature search also revealed that medical management of osteoporosis includes diet control, weight-bearing exercise, discontinuation of tobacco and alcohol intake, and use of medicationsincluding selective estrogen receptor modulators, calcitonin, anabolic agents and bisphosphonatesthat have been associated with the development of osteonecrosis of the jaw.

The authors determined that oral health maintenance is important in patients with osteoporosis, and that changes to bisphosphonate therapy or other medical treatment should be made only after consultation with the patients physician. Dentists need to understand osteoporosis, its treatments and its complications to provide adequate care, write the authors.

All health care professionals involved in the care of all dental patients, particularly patients who are taking oral bisphosphonates, should discuss patient care decisions with the patients physician, conclude the authors.


'/>"/>

Contact: Fred Peterson
petersonf@ada.org
312-440-2855
American Dental Association
Source:Eurekalert

Page: 1

Related medicine news :

1. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
2. Is 4 agents decoction (Si Wu Tang) efficacious in treating primary dysmenorrhea?
3. Treating diabetes during pregnancy can break link to childhood obesity
4. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
5. Treating Diabetes During Pregnancy Could Lead to Thinner Kids
6. Family-based treatment more effective than supportive psychotherapy in treating bulimia
7. Treating depression may improve recovery of heart rate variability following coronary syndromes
8. Antidepressant shows early promise in treating agitation and psychotic symptoms of dementia
9. Hospitals Improve Survival Rates While Treating Sicker Patients Thomson Healthcare Study Shows
10. Stem cells show promise for treating Huntingtons disease
11. Treating obstructive sleep apnea, preventing heart attacks and strokes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... The 2nd annual Ride to Fight On will ... October 3, 2015. The Ride to Fight On is a cycling fundraiser that benefits ... The West Clinic and The University of Tennessee Health Science Center. A health and ...
(Date:7/31/2015)... ... 31, 2015 , ... Coco Libre announced today that their flagship Organic Coconut ... 2015 Vans US Open of Surfing, July 25 through August 2 in Huntington Beach, ... on the market, is a natural choice given the Open’s commitment to sustainable practices. ...
(Date:7/31/2015)... ... July 31, 2015 , ... Well-known for its unique pastries ... wedding cakes with custom designs, making life just a little bit sweeter for ... cakes for each customer who orders one. , The bakery provides a full line ...
(Date:7/31/2015)... ... 2015 , ... Transfinder, a software company based in Schenectady, N.Y., achieved record ... year-over-year for the first six months ended June 30, 2015 compared with the same ... last year’s record-revenue mark of $10.4 million. , “We know what our customers need ...
(Date:7/31/2015)... NY (PRWEB) , ... July 31, 2015 , ... The ... marijuana, on research projects that evaluate the potential of related, experimental treatments. The collaboration ... Department of Health to award Columbia Care one of five state licenses to produce ...
Breaking Medicine News(10 mins):Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Coco Libre Brings Eco-conscious Hydration to Vans US Open of Surfing 2Health News:Pastry Palace of Las Vegas Announces It Is Now Offering Custom Wedding Cakes in Las Vegas 2Health News:Transfinder Closes First Half of 2015 with Record Revenue 2Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 2Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 3
... students to benefit from program targeting kids in five-county ... American dream -- that children have more opportunities and ... at risk as the incidence of obesity among children ... could become the first in this country,s history to ...
... Andre Konski, M.D., M.B.A., has been offered ... Department of Radiation Oncology for the Wayne ... Chief for Radiation Oncology at the Barbara Ann ... Konski comes to Wayne State and ...
... Pierre,s Ice Cream Company, makers of,Hola Fruta!(R) ... innovation,called Yovation(TM). , (Photo: ... Yovation(TM) is a new premium, probiotic frozen ... and popularity of probiotic products and the,recognition by ...
... Plans Thousands of Franchisees Nationally With More than 1,800 ... eMed-ID, the world,s first medical identification franchise, announced today ... provides a personal USB device to consumers containing their ... for consumers to document their private medical history on ...
... Jan. 9 (HealthDay News) -- Parents may not always ... exercise habits, a new study shows. , Researchers reported ... Education and Behavior that mothers of preschool-aged children ... with older children did not. But when the children ...
... enhanced website designed to provide improved accessibility and ... Labs, a Zeus company, announces the launch of ... via the original URL and can be found ... with expanded content, including more information about Polymathic,s ...
Cached Medicine News:Health News:The Archdiocese of Philadelphia and Independence Blue Cross Team Up to Address Childhood Obesity 2Health News:The Archdiocese of Philadelphia and Independence Blue Cross Team Up to Address Childhood Obesity 3Health News:The Archdiocese of Philadelphia and Independence Blue Cross Team Up to Address Childhood Obesity 4Health News:Andre Konski, M.D., M.B.A., Accepts Radiation Oncology Position at Wayne State University and the Karmanos Cancer Institute 2Health News:Andre Konski, M.D., M.B.A., Accepts Radiation Oncology Position at Wayne State University and the Karmanos Cancer Institute 3Health News:Standing Ovation for Pierre's New Innovation! 2Health News:Standing Ovation for Pierre's New Innovation! 3Health News:World's First Medical Identification Franchise Launches at Miami's Franchise Expo South 2Health News:World's First Medical Identification Franchise Launches at Miami's Franchise Expo South 3Health News:Parents Not Best Barometer of Kid's Eating, Exercise Habits 2Health News:Polymathic Analytical Labs Launches New Website 2
(Date:7/30/2015)... , July 30, 2015  OncoGenex Pharmaceuticals, Inc. ... report its second quarter 2015 financial results on Thursday, ... call and live webcast at 4:30 p.m. Eastern Time ... programs and a general corporate update. ... Relations page of the OncoGenex website at www.oncogenex.com ...
(Date:7/30/2015)... PLAINFIELD, N.J., July 30, 2015 PTC Therapeutics, ... update and reported financial results for the second quarter ... progressing on many fronts across the organization.  We are ... Duchenne muscular dystrophy clinical trial ever conducted with topline ... Peltz, Ph.D., Chief Executive Officer, PTC Therapeutics, Inc. "Translarna ...
(Date:7/30/2015)... -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI ) ... patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics ... notice it received on May 21, 2015 from the ... was below certain of the Exchange,s continued listing standards, ... the NYSE MKT Company Guide, due to the delay ...
Breaking Medicine Technology:PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2
... MASI ) today announced that its management is scheduled ... The Pierre Hotel in New York on Tuesday, November 15, ... the presentation will be available on the Masimo website at ... available following the live presentation. About ...
... Nov. 8, 2011 ChemoCentryx, Inc., today announced that ... the Annual Meeting of the American College of Rheumatology ... targets and inhibits the chemokine receptor known as CCR1, ... rheumatoid arthritis (RA).  Results showed that CCX354 was safe ...
Cached Medicine Technology:Masimo to Present at Lazard Capital Markets Healthcare Conference 2ChemoCentryx Reports Clinical Efficacy for CCX354, a Novel CCR1 Inhibitor in a Phase II Study in Patients with Rheumatoid Arthritis 2ChemoCentryx Reports Clinical Efficacy for CCX354, a Novel CCR1 Inhibitor in a Phase II Study in Patients with Rheumatoid Arthritis 3ChemoCentryx Reports Clinical Efficacy for CCX354, a Novel CCR1 Inhibitor in a Phase II Study in Patients with Rheumatoid Arthritis 4
Multipiece PMMA IOL - Sulcus Fixation....
Hydrophilic Acrylic Intraocular Lens (Refractive and Bifocal). Anterior Chamber Lens....
Raysoft Foldable Intraocular Lens....
HAPTIBAG Hydrophilic Acrylic Lens....
Medicine Products: